These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12084405)

  • 1. Effects of progestins in different hormone replacement therapy formulations on estrogen-induced lipid changes in postmenopausal women.
    Shulman LP
    Am J Cardiol; 2002 Jun; 89(12A):47E-54E; discussion 54E-55E. PubMed ID: 12084405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin replacement in the menopause: effects on the endometrium and serum lipids.
    Williams DB; Moley KH
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):284-92. PubMed ID: 8038417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The menopause and hormone replacement therapy: lipids, lipoproteins, coagulation and fibrinolytic factors.
    Tikkanen MJ
    Maturitas; 1996 Mar; 23(2):209-16. PubMed ID: 8735358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for estrogen with interrupted progestin as a new low-dose hormonal replacement therapy.
    Casper RF; MacLusky NJ; Vanin C; Brown TJ
    J Soc Gynecol Investig; 1996; 3(5):225-34. PubMed ID: 8796834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KEEPS: The Kronos Early Estrogen Prevention Study.
    Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
    Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
    Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
    Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and cardioprotection: the end of the tale?
    Rosano GM; Vitale C; Silvestri A; Fini M
    Ann N Y Acad Sci; 2003 Nov; 997():351-7. PubMed ID: 14644842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen with interrupted progestin HRT: a review of experimental and clinical studies.
    Casper RF
    Maturitas; 2000 Feb; 34(2):97-108. PubMed ID: 10714903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative effects of progesterone and progestins in hormone replacement therapy.
    Rosano GM; Sarais C; Zoncu S; Mercuro G
    Hum Reprod; 2000 Jun; 15 Suppl 1():60-73. PubMed ID: 10928419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The varying effects of progestins on lipid levels and cardiovascular disease.
    La Rosa JC
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1621-9. PubMed ID: 3132043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement and the prevention of cardiovascular disease.
    Langer RD
    Am J Cardiol; 2002 Jun; 89(12A):36E-46E; discussion 46E. PubMed ID: 12084403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical profiles of progestins used in formulations of oral contraceptives and hormone replacement therapy.
    Hammond GL; Rabe T; Wagner JD
    Am J Obstet Gynecol; 2001 Aug; 185(2 Suppl):S24-31. PubMed ID: 11521119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.